Myers DE - Search Results

1

Low Dose Total Body Irradiation Combined With Recombinant CD19-Ligand × Soluble TRAIL Fusion Protein is Highly Effective Against Radiation-Resistant B-Precursor Acute Lymphoblastic Leukemia in Mice.

Uckun FM, Myers DE, Ma H, Rose R, Qazi S. Uckun FM, et al. Among authors: myers de. EBioMedicine. 2015 Apr;2(4):306-316. doi: 10.1016/j.ebiom.2015.02.008. EBioMedicine. 2015. PMID: 26097891 Free PMC article.

2

Liposomal Nanoparticles of a Spleen Tyrosine Kinase P-Site Inhibitor Amplify the Potency of Low Dose Total Body Irradiation Against Aggressive B-Precursor Leukemia and Yield Superior Survival Outcomes in Mice.

Uckun FM, Myers DE, Cheng J, Qazi S. Uckun FM, et al. Among authors: myers de. EBioMedicine. 2015 Apr 11;2(6):554-62. doi: 10.1016/j.ebiom.2015.04.005. eCollection 2015 Jun. EBioMedicine. 2015. PMID: 26285772 Free PMC article.

3

Development of Polypeptide-based Nanoparticles for Non-viral Delivery of CD22 RNA Trans-splicing Molecule as a New Precision Medicine Candidate Against B-lineage ALL.

Uckun FM, Mitchell LG, Qazi S, Liu Y, Zheng N, Myers DE, Song Z, Ma H, Cheng J. Uckun FM, et al. Among authors: myers de. EBioMedicine. 2015 Apr 30;2(7):649-59. doi: 10.1016/j.ebiom.2015.04.016. eCollection 2015 Jul. EBioMedicine. 2015. PMID: 26288837 Free PMC article.

4

Rational design of an immunoconjugate for selective knock-down of leukemia-specific E2A-PBX1 fusion gene expression in human Pre-B leukemia.

Uckun FM, Qazi S, Dibirdik I, Myers DE. Uckun FM, et al. Among authors: myers de. Integr Biol (Camb). 2013 Jan;5(1):122-32. doi: 10.1039/c2ib20114c. Integr Biol (Camb). 2013. PMID: 22990208

5

CD19-antigen specific nanoscale liposomal formulation of a SYK P-site inhibitor causes apoptotic destruction of human B-precursor leukemia cells.

Myers DE, Yiv S, Qazi S, Ma H, Cely I, Shahidzadeh A, Arellano M, Finestone E, Gaynon PS, Termuhlen A, Cheng J, Uckun FM. Myers DE, et al. Integr Biol (Camb). 2014 Aug;6(8):766-80. doi: 10.1039/c4ib00095a. Integr Biol (Camb). 2014. PMID: 24910947 Free PMC article.

6

Recombinant human CD19L-sTRAIL effectively targets B cell precursor acute lymphoblastic leukemia.

Uckun FM, Myers DE, Qazi S, Ozer Z, Rose R, D'Cruz OJ, Ma H. Uckun FM, et al. Among authors: myers de. J Clin Invest. 2015 Mar 2;125(3):1006-18. doi: 10.1172/JCI76610. Epub 2015 Jan 26. J Clin Invest. 2015. PMID: 25621496 Free PMC article.

7

CD22ΔE12 as a molecular target for RNAi therapy.

Uckun FM, Ma H, Cheng J, Myers DE, Qazi S. Uckun FM, et al. Among authors: myers de. Br J Haematol. 2015 May;169(3):401-14. doi: 10.1111/bjh.13306. Epub 2015 Feb 6. Br J Haematol. 2015. PMID: 25659406 Free PMC article.

8

Treatment of therapy-refractory B-lineage acute lymphoblastic leukemia with an apoptosis-inducing CD19-directed tyrosine kinase inhibitor.

Uckun FM, Messinger Y, Chen CL, O'Neill K, Myers DE, Goldman F, Hurvitz C, Casper JT, Levine A. Uckun FM, et al. Among authors: myers de. Clin Cancer Res. 1999 Dec;5(12):3906-13. Clin Cancer Res. 1999. PMID: 10632319 Clinical Trial.

9

In vivo toxicity, pharmacokinetic features, and immunogenicity of B43(Anti-CD19)-genistein immunoconjugate in mice and non-human primates.

Myers DE, Uckun FM. Myers DE, et al. J Med Food. 1999;2(3-4):173-5. doi: 10.1089/jmf.1999.2.173. J Med Food. 1999. PMID: 19281372 No abstract available.

10

An anti-CD72 immunotoxin against therapy-refractory B-lineage acute lymphoblastic leukemia.

Myers DE, Uckun FM. Myers DE, et al. Leuk Lymphoma. 1995 Jun;18(1-2):119-22. doi: 10.3109/10428199509064931. Leuk Lymphoma. 1995. PMID: 8580813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters